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Tuberculosis (TB), caused by the Mycobacterium tuberculosis complex bacteria, is
one of the most pressing health problems. The development of new drugs and
new therapeutic regimens effective against the pathogen is one of the greatest
challenges in the way of tuberculosis control. Imidazo[1,2-b][1,2,4,5]tetrazines have
shown promising activity against M. tuberculosis and M. smegmatis strains. Mutations
in MSMEG_1380 lead to mmpS5–mmpL5 operon overexpression, which provides
M. smegmatis with efflux-mediated resistance to imidazo[1,2-b][1,2,4,5]tetrazines, but
the exact mechanism of action of these compounds remains unknown. To assess
the mode of action of imidazo[1,2-b][1,2,4,5]tetrazines, we analyzed the transcriptomic
response of M. smegmatis to three different concentrations of 3a compound: 1/8×,
1/4×, and 1/2× MIC. Six groups of genes responsible for siderophore synthesis and
transport were upregulated in a dose-dependent manner, while virtual docking revealed
proteins involved in siderophore synthesis as possible targets for 3a. Thus, we suggest
that imidazo[1,2-b][1,2,4,5]tetrazines may affect mycobacterial iron metabolism.
Keywords: Mycobacterium, drug resistance, imidazo[1, 2-b][1, 2, 4, 5]tetrazine, transcriptome, drug development,
tuberculosis, virtual screening
INTRODUCTION
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is one of the most successful
bacterial pathogens. Despite many attempts to control the disease, it remains one of the world’s
major health problems that causes more than 1.4 million deaths annually. The situation is
complicated by the emergence of drug-resistant forms of the disease [World Health Organization
(WHO)., 2020]. And if the initial mathematical models suggested that resistant isolates should
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be less transmissible and therefore unlikely to spread successfully
in human populations, now it is clear that compensatory
evolution and other factors drive the successful distribution
of multidrug-resistant tuberculosis (Gagneux, 2009). In turn,
infection with such isolates leads to longer treatment time with
more toxic and costlier than the first-line drugs-based regimens
and low treatment success (Rajbhandary et al., 2004). Hence
there is an urgent need for novel drugs that are active against
M. tuberculosis.
We have previously described imidazo[1,2-
b][1,2,4,5]tetrazines as a class of promising antimycobacterial
agents, with relatively high efficacy against both M. tuberculosis
and M. smegmatis. An original test-system M. smegmatis
aphVIII+ and docking studies showed that eukaryotic type
serine-threonine protein kinases (STPKs) may act as targets
of these compounds (Maslov et al., 2017, 2019). The main
mechanism of resistance to these compounds is provided by
mutations in MSMEG_1380, a transcriptional repressor of
the mmpS5–mmpL5 efflux system. These mutations result
in mmpS5–mmpL5 overexpression and increased efflux of
the compounds from the cell (Maslov et al., 2020). A similar
mechanism of resistance was also shown for bedaquiline and
clofazimine (Hartkoorn et al., 2014), azoles (Milano et al.,
2009), thiacetazone derivatives (Halloum et al., 2017), and
tryptanthrins (Frolova et al., 2021) in various mycobacterial
species. However, the mode of action, as well as biotarget(s) of
imidazo[1,2-b][1,2,4,5]tetrazines have not yet been confirmed
in vitro.
Additionally, we have constructed an M. smegmatis mc2
155 mutant, carrying a 2828 bp deletion in the mmpS5–
mmpL5 operon, namely M. smegmatis 1mmp5, which was
hypersensitive to imidazo[1,2-b][1,2,4,5]tetrazines (Shur et al.,
2021). We used this strain in an attempt to obtain spontaneous
mutants, resistant to the imidazo[1,2-b][1,2,4,5]tetrazines, with a
mechanism different from mmpS5–mmpL5 overexpression, but
could not do it even at a frequency of 10−10. This fact may
indicate that these compounds have more than one biotarget,
making the standard genetic approach useless in this case.
Transcriptomic studies, consisting of the analysis of the total
RNA sequencing (RNA-seq), are now becoming a powerful
tool for establishing additional mechanisms of action of
antimicrobial agents, including anti-TB drugs, through the
bacterial transcriptional response in the presence of the drug.
This approach was used to establish the mechanisms of action
of bedaquiline on dormant M. tuberculosis cells (Hards et al.,
2015), mechanisms of ethionamide resistance of XDR-TB clinical
isolates (Welzen et al., 2017), and to other antibiotics used in
clinical practice (Briffotaux et al., 2019).
In the initial study we have tried to analyze the transcriptomic
response of M. smegmatis to one of the imidazo[1,2-
b][1,2,4,5]tetrazines – 3a (Supplementary Figure 1), treating the
cells with 2× MIC (256 µg/ml) for 90 min, but this has led to
a differential expression of over 1300 genes, making a detailed
analysis rather intricate (Vatlin et al., 2020).
In this work, we describe the transcriptomic analysis
of M. smegmatis in the presence of different subinhibitory
concentrations of the imidazo[1,2-b][1,2,4,5]tetrazine 3a (1/8×,
1/4×, and 1/2× MIC) to get an insight in the gradual changes
in the bacterial response to the increasing amounts of this drug.
We have observed a dose-dependent differential expression of
genes involved in iron acquisition, transport and storage, as well
as other iron-regulated genes, showing a state of iron-starvation
induced by 3a. In turn further virtual docking studies revealed
siderophore synthesis proteins as potential targets of 3a.
MATERIALS AND METHODS
Bacterial Strain and Growth Conditions
Mycobacterium smegmatis mc2 155 was grown in Middlebrook
7H9 medium (Himedia, India) supplemented with oleic albumin
dextrose catalase (OADC, Himedia, India), 0.1% Tween-80
(v/v), and 0.4% glycerol (v/v), while soyabean-casein digest agar
(M290, Himedia, India) and Middlebrook 7H11 agar (Himedia,
India) supplemented with OADC were used as the solid media.
Bacterial cultures in liquid medium were incubated in the
Multitron incubator shaker (Infors HT, Basel, Switzerland) at
37◦C and 250 rpm.
For drug exposure assay and transcriptomic analysis,
M. smegmatis mc2 155 was inoculated from the agarized plates in
7H9 medium and grown until OD600 = 2.5 (two nights) to obtain
a stable liquid culture without clumps, diluted in the proportion
1:200 and cultured overnight until OD600 = 2, then diluted in
the proportion of 1:10 in fresh medium (to an approximate
OD600 = 0.2). 3a 100× stocks were prepared in DMSO and added
to the bacterial cultures to a final concentration corresponding
to 1/8×MIC (16 µg/ml), 1/4×MIC (32 µg/ml), and 1/2×MIC
(64 µg/ml) in 7H9 OADC medium (Maslov et al., 2020). The
same volume of DMSO was added to the control samples (1%
v/v). Bacterial cultures were incubated for 90 min [1/2 of the
cell division time (Logsdon and Aldridge, 2018)] at 37◦C and
250 rpm and proceeded to RNA extraction. The experiments
were carried in three biological replicates.
The paper-disk drug susceptibility assay was performed as
described before (Maslov et al., 2019). Briefly, M. smegmatis mc2
155 was grown in Middlebrook 7H9 broth to midexponential
phase (OD600 = 1.2). Afterwards, the culture was diluted in the
proportion of 1:9:10 (culture:water:M290 medium) and 5 ml
were poured as the top layer on Petri dishes with agarized M290
medium. The plates were allowed to dry for at least 30 min,
afterwards sterile paper disks with impregnated 300 nmol of 3a
were plated. The plates were incubated for 2–3 days at 37◦C, until
the bacterial lawn was fully grown. Growth inhibition halos were
measured to the nearest 1 mm. The experiments were carried out
as triplicates; the average diameter and standard deviation (SD)
were calculated. Those differences that had no intersection of the
SDs with the control were considered significant.
Total RNA Extraction
Cells from 10 ml culture were harvested by centrifugation for
10 min at 3000 × g and 4◦C, washed twice by 10 ml of fresh
Middlebrook 7H9 broth to remove the traces of 3a and DMSO
and once by 3 ml of RNAprotect Bacteria Reagent (Qiagen,
United States) for RNA stabilization. M. smegmatis cells were
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homogenized in ExtractRNA reagent (Evrogen, Russia), followed
by phenol (pH = 4.5)-chloroform-isoamyl alcohol (25:24:1)
purification and precipitation with isopropanol (2:1, v/v).
DNase treatment was carried out as previously described
(Bespyatykh et al., 2019) with TURBO DNA-free kit (Thermo
Fisher Scientific, Waltham, MA, United States), in volumes of
100 µl, and further with the RNase-Free DNase Set (Qiagen,
Hilden, Germany), according to the manufacturers’ protocol.
RNA cleanup was performed with the RNeasy Mini Kit (Qiagen).
The concentration and quality of the total RNA were checked by
the Quant-it RiboGreen RNA assay (Thermo Fisher Scientific)
and the RNA 6000 Pico chip (Agilent Technologies, Santa Clara,
CA, United States), respectively.
Library Preparation and RNA Sequencing
Total RNA (1 µg) was used for library preparation as previously
described (Bespyatykh et al., 2020) with some modifications.
Ribosomal RNA was removed from the total RNA using the
Ribo-Zero Plus rRNA Depletion Kit (Illumina, United States) and
libraries were prepared using the NEBNext Ultra II Directional
RNA Library Prep Kit (NEB), according to the manufacturer’s
protocol. Subsequently, RNA cleanup was performed with
the Agencourt RNA Clean XP kit (Beckman Coulter, Brea,
United States). The library underwent a final cleanup using the
Agencourt AMPure XP system (Beckman Coulter) after which
the libraries’ size distribution and quality were assessed using
a high sensitivity DNA chip (Agilent Technologies). Libraries
were subsequently quantified by Quant-iT DNA Assay Kit,
High Sensitivity (Thermo Fisher Scientific). Finally, equimolar
quantities of all libraries (12 pM) were sequenced by a high
throughput run on the Illumina HiSeq using 2 × 100 bp paired-
end reads and a 5% Phix spike-in control. RNA-seq read data
were deposited to the NCBI Sequence Read Archive under
accession number PRJNA615922.
Bioinformatics Analysis
Quality control of the raw sequencing data was performed
using FastQC (v.0.11.9) (Andrews, 2010), individual reports were
merged with MultiQC (v.1.9) (Ewels et al., 2016). Adapters and
low-quality reads were removed using Trimmomatic (v.0.39)
(Bolger et al., 2014). HISAT2 (v.2.2.1) (Kim et al., 2019) was
used to map trimmed reads to the reference M. smegmatis mc2
155 genome (CP000480.1). Mapping quality and coverage along
genes were assessed with QualiMap (v.2.2.2) (Okonechnikov
et al., 2016). Mapped reads were assigned to genes with
featureCounts (v.2.0.1) (Liao et al., 2014). Differential gene
expression (DGE) analysis was performed using the edgeR
(v.3.30.3) (Robinson et al., 2010) for R (v.4.0.2) (R Core
Team, 2020). Genes with a false discovery rate (FDR) cutoff
of 0.001 and fold change (FC) log2FC ≥ 1, or log2FC ≤ −1
were considered to be differentially expressed. Plots were
generated within R (v.4.0.2) using ggplot2 (v.3.3.2) (Wickham,
2009) and cowplot (v.1.1.0) (Wilke, 2016) packages. Further
functional enrichment analysis of the COG categories and Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways for
differentially expressed genes (DEGs) was performed using the
DAVID (v.6.8) (Huang et al., 2009) database, categories were
considered enriched with p ≤ 0.05.
Virtual Screening Studies
To understand the effect of the imidazo[1,2-b][1,2,4,5]tetrazine
on the structures of proteins associated with the iron metabolism
in M. smegmatis, the molecular docking was performed using
AutoDock vina (Trott and Olson, 2010). Primarily, the sequence
information regarding the listed protein was obtained from
the UniProt.1 As the majority of proteins don’t have X-ray
crystallographic (X-ray) structures available in the biological
database, therefore, the SWISS-MODEL was used which is very
efficient in modeling proteins with amino acid numbers as
large as 5000 (Schwede et al., 2003). The 3-D coordinates of
the respective proteins were prepared and optimized using the
utilities of MAESTRO (Schrödinger Release 2018-1: Maestro,
Schrödinger, LLC, New York, NY, United States, 2018) and
the obtained structures were energetically minimized using
the modules present in JAGUAR (Bochevarov et al., 2013).
Consequently, the docking was performed using AutoDock
vina and docked conformations were predicted through the
combination of free energy functionals, empirical force field and
the Lamarckian Genetic Algorithm (Trott and Olson, 2010). The
dimensional space of 40 × 40 × 40 Å was set along the XYZ
directions with varied central coordinates and the spacing was set
to the 0.375 Å. To achieve the maximum accuracy, the parameters
were set to the highest efficiency range.
RESULTS
Transcriptional Response of
M. smegmatis to 3a Treatment – KEGG
Analysis
To evaluate the changes in bacterial metabolism during 3a
treatment, the transcriptomic profiles of M. smegmatis mc2
155 strain exposed to 3a at 1/8×, 1/4×, and 1/2× MIC for
a duration of 90 min were examined. In total, approximately
6000 quantifiable transcripts were identified for each experiment.
These results are comparable to the RNA-seq of the DMSO-
treated cells (control) and correspond to almost complete
coverage of the genome. A non-metric multidimensional scaling
analysis showed a clear separation between samples exposed to
different 3a concentrations (Supplementary Figure 2).
Analysis of DEGs revealed that 3a significantly (log2FC ≥ 1,
or log2FC ≤ −1, FDR < 0.001) variates the expression level of
numerous genes. We observed that 7.4% (452/6079) genes were
upregulated and 14.1% (856/6079) were downregulated upon
exposure to 16 µg/ml 3a, with these numbers increasing up
to 13.9 and 14.9%, respectively, at the exposure to 64 µg/ml
3a, as compared to the control (Supplementary Table 1).
We were able to detect a dose-dependent effect (at least a
twofold increase or decrease of expression FC, upon twofold
increase in 3a concentration) for 120 and 173 genes, respectively
1https://uniprot.org
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(Supplementary Table 2). Upon implementation of an additional
filter (at least a 2× FC at 1/4× MIC relative to 1/8× MIC,
and at least a 2× FC at 1/2× MIC relative to 1/4× MIC) we
were left with just 31 overexpressed and 11 underexpressed genes
(Supplementary Table 3). Among those 31 overexpressed genes,
25 were related to iron acquisition and transport (exochelin
synthesis and transport, mbt-1 and mbt-2 clusters, ESX-3 operon
and a gene encoding a siderophore-interacting protein).
DAVID functional annotation tool was used to infer enriched
KEGG pathways from sets of upregulated DEGs. Enriched
pathway (p < 0.05) that was present in all MICs was “biosynthesis
of siderophore group non-ribosomal peptides,” and comprised
eight genes (MSMEG_4509–MSMEG_4513, MSMEG_4515,
MSMEG_4516, and MSMEG_4524) in all concentrations of the
compound (Figure 1).
Dose-Dependent Gene Regulation
Reveals Further Impact of
Imidazo[1,2-b][1,2,4,5]tetrazine on Iron
Metabolism
Since the siderophore biosynthesis KEGG pathway was enriched
in response to 3a exposure (Figure 1), we have decided to
conduct a deeper analysis of the genes involved in the iron
metabolism (Figure 2), using their homologs in M. tuberculosis
H37Rv according to Namouchi et al. (2017) as an additional
reference, as more data is published for this organism.
We have found that in compliance with the KEGG analysis,
the mbt gene clusters were upregulated in a dose-dependent
manner (Figure 2). These operons are the key elements
of the “biosynthesis of siderophore group non-ribosomal
peptides” pathway, which is responsible for the synthesis of
the most important iron-chelating compounds – siderophores
(mycobactin and carboxymycobactin in mycobacteria) (Chao
et al., 2018). Similar changes were observed for the biosynthesis
of exochelin, which is specific for non-virulent mycobacteria
(Ratledge and Ewing, 1996). Opposite changes have been
shown in iron storage genes bfrA and bfrB (Reddy et al.,
2012), expression of which declined with increasing dose
of the compound.
Overexpression of genes involved in iron and siderophore
acquisition and transport was also observed (Figure 2). Among
these overexpressed genes was ESX-3 operon, which is a vital
core operon and is part of the type VII secretion system
(T7SS), responsible for iron acquisition and controlled by
the iron-dependent transcriptional repressor (IdeR) (Ioerger
et al., 2013). The iron-dependent transporters irtA and irtB
(Ryndak et al., 2010), and the genes of the mmpS5–mmpL5
siderophore transport system (Wells et al., 2013) were also
amidst overexpressed genes, though mmpS4–mmpL4 genes
were downregulated.
In silico Interaction Studies Reveal
Siderophore Synthesis Genes as
Potential 3a Targets
As the transcriptomic analysis revealed the overexpression of
iron acquisition and transport genes in response to 3a exposure,
with the highest impact observed for siderophore synthesis
genes. Therefore, to understand the structural complementarity
of 3a with the selected 46 overexpressed genes, an extensive
molecular docking study was performed, which revealed the
binding preferences of the inhibitor molecule. Consequently,
streamlined filtering enabled the selection of specific protein
targets such as protein FxuA which is considered to be
significant in the biosynthesis of exochelin, one of the two
siderophores present in M. smegmatis which are involved in
iron transport (Fiss et al., 1994). Similarly, FxbA which was
identified to be a putative formyltransferase catalyzed the
addition of the formyl group in the exochelin biosynthesis
(Fiss et al., 1994). Through docking studies, it was observed
that the imidazo[1,2-b][1,2,4,5]tetrazine was bonded with the
highest affinity to the structure of FxuA followed by FxbA
with free energies of interaction −8.0 and −7.8 kcal/mol,
respectively, among the 46 docked systems (Table 1). These
observations showed that the activity of exochelin could be
inhibited to a relatively higher extent by the administration of
imidazo[1,2-b][1,2,4,5]tetrazine. The compound was observed
to be interacting with Ser41, Thr42, Trp68, Arg69, Arg72, and
Leu309 of FxuA, while for FxbA the interactions were observed
with Ala85, Asn87, Trp88, Thr90, Asn106, His108, Phe118, and
Leu143 (Supplementary Figures 3, 4). The output of MetaPocket
(Huang, 2009) revealed that the respective interacting residues
form the part of ligand binding cavities. Furthermore, among the
mycobactin biosynthesis enzymes, the highest binding affinities
were observed with MbtC and MbtD with calculated free energies
of −7.7 kcal/mol (Table 1). The MbtC binding pocket contains
Pro282, His311, Thr313, Gly318, Phe415, and Met417, while
for MbtD the amino acids Gln104, His190, Ala262, Ile287, and
Val293 were observed in the interaction pocket (Supplementary
Figures 5, 6). Similar binding affinity was observed for FxbC
with the free energy of −7.7 kcal/mol and interacting residues
are Ser1718, Phe1762, Phe1764, Ile1863, Thr1864, and His2004
(Supplementary Figure 7). Moreover, a relatively higher binding
affinity of −7.8 kcal/mol was observed for EccA3 protein which
was characterized to be a member of CbbX family ATPases
involved in the ESX-3 secretory pathway (Gaur et al., 2017). We
observed that the EccA3 contains the residues Pro366, Glu542,
Arg543, Ser545, Ala549, Tyr648, and Arg469 in the docked
pocket of the protein (Supplementary Figure 8).
Addition of Iron to the Growth Medium
Reduces M. smegmatis 3a Susceptibility
We have previously observed that M. smegmatis had different
3a MIC values in 7H9 + OADC and Lemco-Tw medium (128
and 64 µg/ml, respectively) (Maslov et al., 2019, 2020). With
our findings, that 3a could lead to iron starvation by inhibiting
siderophore synthesis, this could be due to the additional iron in
the composition of Middlebrook 7H9 broth in the form of ferric
ammonium citrate.
To prove this hypothesis, we have additionally tested
M. smegmatis susceptibility to 3a by paper disk method on
solid media with different iron content: soyabean digest agar
(no iron in the composition), soyabean digest agar with
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FIGURE 1 | Kyoto Encyclopedia ofGenes and Genomes enrichment analysis of DEGs in exposed to 3a samples with different MICs. Y-axis represents KEGG
pathways, X-axis represents fold enrichment (amount of input pathway DEGs/background gene set, ≥1.5 considered as interesting). Dots colors represent the
p-values of enrichment, the dots’ size represents the gene number in the pathway.
2.5 mM FeSO4, and Middlebrook 7H11 + OADC medium
(containing 40 mg/l ferric ammonium citrate, ∼150 µM).
M. smegmatis showed higher resistance on both iron-
supplemented media as compared to the iron-free soyabean
digest agar, confirming that the addition of iron reduces the
susceptibility of bacterial cells to 3a, presumably by reducing the
iron starvation (Figure 3).
DISCUSSION
The transcriptomic analysis of M. smegmatis mc2 155, exposed
to increasing doses of the imidazo[1,2-b][1,2,4,5]tetrazine 3a
has revealed a dose-dependent change in the expression of
many genes involved in iron metabolism, including the genes
responsible for siderophore synthesis and transport: the gene
cluster responsible for exochelin synthesis and transport, mbtA-
G and mbtK-N clusters, ESX-3 operon, irtA-B, mmpS5–mmpL5,
and bfrA-B operons.
Our observations based on docking studies suggest that
imidazo[1,2-b][1,2,4,5]tetrazine 3a could inhibit the iron
metabolizing enzymes and may target the proteins involved in
mycobactin biosynthesis, but relatively higher affinities were
observed with the proteins involved in exochelin biosynthetic
pathways. Virtual screening showed that FxuA is the most likely
target of 3a, followed by FxbA, MbtC, mbtD, and FxbC. The
inhibition of siderophores’ synthesis by 3a could lead to the
low-iron conditions transcriptomic profile, observed in our
study with a few exceptions. This mechanism could also explain
a higher sensitivity of M. tuberculosis strains to imidazo[1,2-
b][1,2,4,5]tetrazines (Maslov et al., 2019), as M. tuberculosis is
more sensitive to iron starvation as a human pathogen (Doherty,
2007; Skaar, 2010), as well as the higher 3a MIC in 7H9 medium
(128 µg/ml), containing ferric ammonium citrate, as compared
to the Lemco-Tw broth (64 µg/ml), which contains no additional
iron in its composition (Maslov et al., 2019, 2020). As shown
in this study, the addition of iron reduced M. smegmatis 3a
susceptibility on agarized medium as well.
Exochelin is a siderophore specific to non-virulent
mycobacteria (Ratledge and Ewing, 1996). The products of
the mbtA-G and mbtK-N gene clusters are part of a complex
mechanism for the synthesis of siderophores in the cell. Mutation
of any mbt gene can disrupt the synthesis of siderophores, which,
in turn, prevents bacteria from assimilating iron from the
environment, leading to impaired cell growth. It was shown
that the M. tuberculosis H37Rv mutant, in which the mbtB gene
was replaced by recombination with a hygromycin resistance
cassette, was restricted for growth in a medium with limited iron
but grew normally in a medium with a high iron content (Voss
et al., 2000). The ESX-3 operon encodes a type VII secretion
system. These systems are common in mycobacteria (Bitter et al.,
2009) and represent a complex with many components and
many substrates. The function of these systems has not yet been
fully studied, however, there is evidence of their involvement in
the secretion of virulence factors and host–pathogen interaction
in M. tuberculosis (Bitter et al., 2009). Both mbtA-G genes
products and type VII secretion systems are currently considered
promising targets for new anti-TB drugs (Bottai et al., 2014;
Maganti et al., 2014).
The mbtA-G, ESX-3, mmpS5–mmpL5, and irtA-B are
controlled by HupB and iron levels (Pandey et al., 2014b), some
of them in IdeR-dependent (mbtA-G, bfrA-B) and others in
the IdeR-independent way (Rodriguez et al., 2002). HupB and
IdeR are two key regulators of iron metabolism in mycobacteria
(Rodriguez et al., 2002; Pandey et al., 2014b). HupB is a
22 kDa (214 a.a.) protein with a C-terminal region unique to
mycobacteria. The orthologs of HupB in mycobacterial species
differ by about 20–30% in their amino acid sequence. HupB
binds to the 10 bp region (HupB-box) and activates its regulated
genes’ expression (Pandey et al., 2014b), while IdeR acts as
a transcription repressor: in high-iron conditions, two IdeR
proteins form a complex with Fe2+ ions and is able to bind to
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FIGURE 2 | Heatmap showing log2-transformed fold change in expression levels of iron metabolites during 3a exposure. M. smegmatis mc2 155 locus tags
(MSMEG_*) are indicated to the left of the heatmap, and M. tuberculosis H37Rv locus tags (Rv*) are indicated to the right of the heatmap, genes’ names are relative
to M. smegmatis mc2 155. Genes with FDR > 0.001 are shown in gray.
the IdeR-box, preventing the start of transcription (Rodriguez
et al., 2002). When iron level is low, the IdeR-Fe2+ complex
is disrupted, and transcription is enabled. In another study by
Pandey et al. (2014a) it has been shown that the promoter region
of hupB contains 2 IdeR-boxes and a HupB-box, suggesting
that hupB could also be regulated by HupB/IdeR system
(self-upregulated in low-iron conditions). While it has been
shown in vitro, that HupB and IdeR can both bind to the hupB
promoter (Pandey et al., 2014a), the upregulation of HupB was
not observed in low-iron conditions in other HupB/IdeR-related
studies (Rodriguez et al., 2002; Pandey et al., 2014b), meaning
that this mechanism is not necessarily functional in the cell
culture. We did not observe any hupB upregulation as well.
The HupB/IdeR was reported to be regulated by mycobacterial
STPKs PknE, PknF, and PknB (Gupta et al., 2014). Our previous
studies showed that 3a could be docked in the PknB adenine-
binding socket (Bekker et al., 2012). However, our current
docking studies revealed lower affinity of 3a toward PknE and
PknB (−6.8 and −7.3 kcal/mol, respectively) and to PknF
homologs in M. smegmatis (ranging from−6.3 to−7.3 kcal/mol),
meaning that these proteins could be not the primary targets
for this compound. The fact that some iron-sensitive, but
HupB/IdeR-independent genes, such as the nuo and pqqE–lldD1
operons (Rodriguez et al., 2002) changed their fold expression
dose-dependently (Supplementary Table 1), supports the theory
of HupB/IdeR-independent mode of action for 3a.
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TABLE 1 | List of differential inhibitory efficiency in the form of free energy of
binding for against the proteins involved in iron acquisition and transport in
M. smegmatis.
S. No M. smegmatis locus tag Protein symbol Free energy (kcal/mol)
Exochelin synthesis and transport
1 MSMEG_0012 FxuC −6.9
2 MSMEG_0013 FxuA −8.0
3 MSMEG_0015 FxuB −6.3
4 MSMEG_0014 FxbA −7.8
5 MSMEG_0017 ExiT −6.6
6 MSMEG_0018 ExiT −6.8
7 MSMEG_0019 FxbB −7.0
8 MSMEG_0019 FxbC −7.7
9 MSMEG_0020 FxuD −5.7
Mbt-1 cluster
10 MSMEG_4508 MbtH −5.4
11 MSMEG_4509 MbtG −7.2
12 MSMEG_4510 MbtF −7.1
13 MSMEG_4511 MbtE −7.6
14 MSMEG_4512 MbtD −7.7
15 MSMEG_4513 MbtC −7.7
16 MSMEG_4514 MbtT −6.6
17 MSMEG_4515 MbtB −7.2
18 MSMEG_4516 MbtA −7.6
19 MSMEG_4524 MbtI −6.8
Mbt-2 cluster
20 MSMEG_2128 MbtK −7.4
21 MSMEG_2130 MbtN −7.1
22 MSMEG_2131 MbtM −7.0
23 MSMEG_2132 MbtL −5.7
Esx-3 secretion system
24 MSMEG_0615 EccA3 −7.8
25 MSMEG_0616 EccB3 −5.4
26 MSMEG_0617 EccC3 −6.9
27 MSMEG_0618 PE −5.7
28 MSMEG_0619 PPE −5.8
29 MSMEG_0620 EsxG −6.1
30 MSMEG_0621 EsxH −5.1
31 MSMEG_0622 EspG3 −6.8
32 MSMEG_0623 EccD3 −6.5
33 MSMEG_0624 MycP3 −6.9
34 MSMEG_0626 EccE3 −6.5
Mycobactin import
35 MSMEG_6553 IrtB −6.5
36 MSMEG_6554 IrtA −6.8
Mycobactin export
37 MSMEG_0380 MmpS4 −6.0
38 MSMEG_0382 MmpL4 −7.1
39 MSMEG_0225 MmpL5 −7.2
40 MSMEG_0226 MmpS5 −6.8
(Continued)
TABLE 1 | Continued
S. No M. smegmatis locus tag Protein symbol Free energy (kcal/mol)
41 MSMEG_1381 MmpS5 −6.3
42 MSMEG_1382 MmpL5 −6.7
43 MSMEG_3495 MmpS5 −6.6
44 MSMEG_3496 MmpL5 −7.5
Iron storage
45 MSMEG_3564 BfrA −5.9
46 MSMEG_6422 BfrB −6.0
FIGURE 3 | Growth inhibition halos, produced by 3a (300 nmol/disk) on
M. smegmatis mc2 155 on different media: soyabean digest agar (M290),
soyabean digest agar + 2.5 mM FeSO4, and 7H11 + OADC. Columns
represent the average growth inhibition halo diameters, while the error bars
represent the standard deviation, calculated from three experiments.
The MmpS4–MmpL4 and MmpS5–MmpL5 were shown
to be crucial for siderophore transport in M. tuberculosis
(Wells et al., 2013). Our transcriptomic data shows, that the
MSMEG_1381–MSMEG_1382 system might play the primary
role in siderophore efflux in M. smegmatis among the 3 homologs
present in the genome. Our failure to obtain spontaneous
3a-resistant mutants using the M. smegmatis 1mmp5 strain
could be caused by the accumulation of siderophores in
the cell, caused by 3a-induced siderophore synthesis and
the inability to provide their efflux. As the siderophores
can be toxic to mycobacterial cells at high concentrations
(Jones et al., 2014), this could provide a synergistic effect,
requiring more than 1 mutation to override it, and thus
drastically lowering the frequency of spontaneous drug-resistant
mutants’ emergence.
The understanding of a drug mode of action can be
crucial in its development, especially in terms of its structure
optimization. We have previously described a set of imidazo[1,2-
b][1,2,4,5]tetrazines as promising anti-TB drug candidates
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and shown that mutations leading to mmpS5–mmpL5
operon overexpression provide M. smegmatis efflux-mediated
resistance to these compounds. We now show, using the
transcriptomic analysis of M. smegmatis exposed to different
doses of imidazo[1,2-b][1,2,4,5]tetrazine 3a, combined with
virtual screening approaches, that this compound may be
targeting mycobacterial iron-uptake pathways by inhibiting
siderophore synthesis.
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